CSL Shares Plunge Most Ever After Impairments, Profit Target Cut

Posted 4 hours ago by

Bloomberg

CSL Ltd. shares dropped the most on record after the Australian biotechnology company cut its full-year outlook and flagged about 5 billion in additional impairments, saying a turnaround will take longer than expected after a review by its interim chief executive.